$1,643,859,160
Department of Health and Human Services·Centers for Disease Control and Prevention
WORK BEGAN2019-08-01·LATEST ACTION2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_NU50CK000517_075
Award description
THE EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES(ELC)
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: high
In plain English
The latest obligation on a 2019 CDC cooperative agreement funding New York City's epidemiology and laboratory capacity for infectious disease prevention and control.
Sub-sectors
public-health-infrastructureinfectious-disease-surveillancecooperative-agreement
Why this matters
Sustains core U.S. disease surveillance and response infrastructure in the nation's largest city, critical for early detection of emerging pathogens.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-17. Cost: $0.002757.
Period of performance
Start
2019-08-01
End
2027-07-31
Status
activein 396 days
Other awards from this recipient
- 2026-05-21HIV EMERGENCY RELIEF PROJECT GRANTS$735.2M
- 2026-04-20CDC-RFA-IP19-1901 IMMUNIZATION AND VACCINES FOR CHILDREN$279.7M
- 2026-04-06EXTENSION OF THE WORLD TRADE CENTER REGISTRY$119.8M
- 2026-04-20ENDING THE HIV EPIDEMIC: A PLAN FOR AMERICA ? RYAN WHITE HIV/AIDS PROGRAM PARTS A AND B$84.4M
- 2026-03-20STRENGTHENING STD PREVENTION AND CONTROL FOR HEALTH DEPARTMENTS (STD PCHD).$60.0M
Sources
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_NU50CK000517_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.